10x Genomics (TXG) Inventory Average (2019 - 2026)

10x Genomics' Inventory Average history runs 8 years deep, the most recent figure standing at $54.9 million for Q1 2026.

• In Q1 2026, Inventory Average fell 30.41% year-over-year to $54.9 million; the TTM figure through Mar 2026 stood at $54.9 million (down 30.41% YoY), while the FY2025 annual figure was $69.7 million, down 11.07% from the prior year.
• Inventory Average came in at $54.9 million for Q1 2026 at 10x Genomics, down from $59.1 million in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $91.2 million in Q3 2024 to a low of $54.9 million in Q1 2026.
• A 5-year average of $75.4 million and a median of $78.4 million in 2024 frame the typical range for Inventory Average.
• Across the five-year window, Inventory Average surged 80.62% in 2022 and plunged 33.22% in 2025, its largest moves.
• 10x Genomics' Inventory Average stood at $80.1 million in 2022, then retreated by 3.52% to $77.3 million in 2023, then grew by 14.57% to $88.6 million in 2024, then slumped by 33.22% to $59.1 million in 2025, then retreated by 7.16% to $54.9 million in 2026.
• According to Business Quant data, Inventory Average over the past three periods registered $54.9 million, $59.1 million, and $65.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison